Macro Dashboard
| Indicator | Level | 5-Day Δ | Signal |
|---|---|---|---|
| KOSPI | 6,806.9 | −11.1% | Bear |
| KOSDAQ | 799.4 | −3.8% | Bear |
| USD/KRW | 1,493 | −2.3% (KRW +) | Neutral |
| VIX | 16.25 | +4.4% | Calm |
| US 10Y | 4.57% | +9bps | Slight rise |
| Brent | $78.55 | +0.7% | Stable |
Regime: KR Bear / US Neutral. KOSPI’s five-day drawdown of −11.1% dwarfs KOSDAQ’s −3.8%, a 7.3pp size-skew gap that points to concentrated large-cap pressure rather than a broad market collapse. Derivative flows confirm: the market program sold a net ₩1.77tn while ETF net creation absorbed ₩961bn — passive inflows partially cushioning active-side exits. Futures basis at +11.22 shows mild premium. Breadth reads 50% of stocks above both the 50MA and 200MA, which keeps the underlying stock-selection environment in neutral territory even as the headline index prints Bear.
Market Wrap
Today was a flow-shock session, not a fundamental reset. KOSPI breached 6,800 intraday as foreign investors registered a net ₩2.45tn sell and institutions added ₩680bn of net supply — one of the heavier combined-flow days of recent months.
Three forces drove the risk-off tone:
1. Leverage ETF regulation noise. Policy discussions around leveraged ETF products unsettled short-term positioning in high-beta, momentum-heavy names, with semiconductor megacaps bearing the brunt.
2. SK Hynix (000660.KS) earnings estimate cuts. Sell-side models trimmed long-term contract profit estimates for SK Hynix, triggering sympathy pressure across the memory supply chain. Samsung Electronics (005930.KS) closed at ₩254,500 with both foreign and institutional investors on the sell side.
3. US CPI pre-positioning. With the July 14 US CPI print on deck, global risk appetite was already thin. Korea’s structural beta to US macro sentiment amplified what would otherwise have been a contained adjustment.
The countervailing data point: TSMC’s June revenue came in at +67.9% YoY, with 2Q beating consensus by 0.4%. That argues against a structural AI demand destruction thesis — today’s selloff reads as a positioning and regulatory uncertainty event, not a demand inflection. Breadth holding at 50% above key moving averages supports that read.
Today’s Quality Re-Rating Candidates
Data note: Today’s daily operational screeners ran with errors and produced no fresh ranked output. The Meta Screener (dated 2026-07-13) uses today’s Kiwoom Market Surface for flow overlays, but the underlying Quality Compounder, Smart Money, Cycle Rerating, and PEAD signals are sourced from the 2026-07-07 screener run. All candidates below are a research queue — verify current price and flow data before drawing conclusions.
The editorial lens: good businesses where capital is entering and the market is beginning to re-price the story. Three layers checked — quality (durable business fundamentals), money flow (institutional/foreign footprint), and re-rating catalyst (earnings leverage being recognized in price).
Candidate Table
| Rank | Ticker | Name | Meta Score | Screeners | Key Metrics |
|---|---|---|---|---|---|
| 1 | 161890.KS | Korea Kolmar | 76.9 | QC · SMQ · CR · SME (4) | ROE 14.7%, OP YoY +23.6%, Margin +0.9pp |
| 2 | 278470.KS | APR | 70.9 | QC · SMQ · SME · PEAD (4) | ROE 65.0%, OP YoY +197.9%, Margin +7.0pp |
| 3 | 096530.KQ | Seegene | 69.4 | QC · SMQ · CR · SME (4) | ROE 4.8%, OP YoY +309.7%, Margin +11.3pp |
| 4 | 420770.KQ | Gigabis | 62.6 | QC · CR · Cons.Up (3) | ROE 7.3%, OP YoY +777.2%, Margin +29.9pp |
| 5 | 089970.KQ | VM | 57.7 | QC · CR (2 + DART catalyst) | ROE 14.7%, OP YoY +386.9%, Margin +29.3pp |
| 6 | 009150.KS | Samsung Electro-Mechanics | 48.2 | QC · CR (2 + IR catalyst) | ROE 7.4%, OP YoY +24.3%, Margin +0.9pp |
| 7 | 271560.KS | Orion | 44.4 | QC · RS80 (2 + prelim earnings) | ROE 10.5%, OP YoY +2.7% |
| 8 | 000660.KS | SK Hynix | 41.9 | QC · CR (2, DART risk ×2) | ROE 35.6%, OP YoY +101.2%, Margin +13.1pp |
QC = Quality Compounder · SMQ = Smart Money Quality · CR = Cycle Rerating · SME = Smart Money Earnings · Cons.Up = Consensus Up Revision · RS80 = RS80 Not-Late Leadership
Top 3 in Brief
Korea Kolmar (161890.KS) — Meta #1, score 76.9 Korea Kolmar is a cosmetics OEM/ODM manufacturer with China-export exposure. It clears four screeners at once: Quality Compounder (ROE 14.7%), Smart Money Quality (5-day institutional/foreign net buying of +₩5.4bn absorbing ₩12.8bn of retail selling), Cycle Rerating (margin expansion +0.9pp), and Smart Money Earnings (OP YoY +23.6%, net income +34.2%). A confirmed IR event filed with DART on July 6 adds a near-term investor communication catalyst. Caution: short interest sits at 7.0% and program selling at −24.1% — technical overhang worth tracking.
APR (278470.KS) — Meta #2, score 70.9 APR operates K-beauty direct-to-consumer brands including Medicube. Growth metrics are outsized: ROE 65.0%, OP YoY +197.9%, revenue YoY +111.3%. It ranks #1 in the PEAD screener (post-earnings drift composite score +1.99, highest in this cohort) and tops both Smart Money Quality and Smart Money Earnings. The nuance: the 5-day net foreign/quality-institutional flow is −₩13.0bn with retail investors on the buy side — institutional momentum is the key variable to recheck against more recent data. The fundamental case remains intact; current flow direction needs verification.
Seegene (096530.KQ) — Meta #3, score 69.4 Seegene is a PCR-based molecular diagnostics company emerging as an earnings inflection story. Four screeners: Quality Compounder, Smart Money Quality, Cycle Rerating (OP YoY +309.7% — the strongest operating income recovery in this cohort, margin expansion +11.3pp), and Smart Money Earnings. The 5-day flow pattern is clean: institutional/foreign net buying of +₩2.4bn against retail distribution of −₩5.2bn. Short interest at 14.2% is elevated and creates two-sided risk — potential squeeze catalyst if the earnings story firms, or a crowded-short overhang if it stalls. Program flow positive at +10.9%.
All figures sourced from the 2026-07-13 KR Meta Screener and 2026-07-13 KR Close Briefing. Underlying screener data dated 2026-07-07. This is market analysis, not investment advice.